Can You Take LDN With Other Medications? Opioids, GLP-1s, Antidepressants, Thyroid Medication, Biologics, and Supplements

Low Dose Naltrexone, commonly called LDN, is often discussed alongside treatments for chronic pain, autoimmune symptoms, thyroid disease, mood disorders, and metabolic health. That means many people considering LDN are already taking several prescriptions, over-the-counter products, or supplements.

So, can LDN be taken with other medications?

The answer depends on the exact medication. Opioids are the clearest and most important conflict because naltrexone blocks opioid receptors and can interfere with pain relief or precipitate withdrawal in a person who is opioid dependent. Other combinations, including GLP-1 medications, antidepressants, thyroid replacement, biologics, and supplements, are not governed by one universal rule. They require a patient-specific review of the complete medication list, medical history, treatment goals, and monitoring plan.

If you are new to the medicine, begin with Scripx Pharmacy’s guide to what Low Dose Naltrexone is, including its uses, evidence, safety, and compounding.

Direct answer: LDN should not be combined with opioid medications unless a qualified clinician who understands the patient’s opioid exposure is directly managing the plan. Some patients may be prescribed LDN alongside nonopioid medications, including a GLP-1, antidepressant, thyroid medicine, biologic, or supplement. However, the absence of a well-documented interaction does not prove that every combination is safe, effective, or appropriate.

Why a Low Dose Still Requires a Full Medication Review

LDN uses the same active ingredient as standard naltrexone, an opioid receptor antagonist. The term “low dose” describes how naltrexone is being prescribed. It does not erase the medication’s pharmacology, eliminate the opioid interaction, or guarantee compatibility with every other treatment.

This distinction is especially important because formal interaction studies are limited. The current naltrexone prescribing information on DailyMed states that studies evaluating interactions with drugs other than opioids have not been performed and advises caution when naltrexone is administered with other medications.

That does not mean naltrexone interacts dangerously with every medicine. It means online interaction checkers and broad statements such as “no interaction found” should not replace clinical judgment.

A useful medication review should include:

1. Prescription medicines

2. As-needed pain, cough, cold, and diarrhea products

3. Medications from other clinicians

4. Weight-management and diabetes treatments

5. Vitamins, herbs, and dietary supplements

6. Recent opioid exposure

7. Planned surgery, dental work, or procedures

8. Liver and kidney history

9. Pregnancy or breastfeeding considerations

10. New or worsening symptoms after any medication change

Patients can also review Scripx’s complete guide to LDN side effects and the opioid safety issue.

LDN and Opioids: The Interaction That Cannot Be Overlooked

The opioid interaction is not a theoretical concern.

Standard naltrexone labeling lists use in patients receiving opioid analgesics, patients with current physiologic opioid dependence, and patients in acute opioid withdrawal as contraindications. Naltrexone can block the expected effects of opioid pain medicine. In an opioid-dependent person, it can precipitate an abrupt and potentially severe withdrawal syndrome.

The medication list should therefore screen for more than familiar pain medicines. Relevant opioid exposure may include:

1. Prescription opioid pain relievers

2. Tramadol

3. Methadone

4. Buprenorphine-containing treatment

5. Certain opioid-containing cough medicines

6. Certain opioid-containing antidiarrheal medicines

7. Recent postoperative or emergency opioid treatment

Patients should not create their own opioid-free interval, stop an opioid suddenly, or try to overcome naltrexone’s blockade by taking more opioid medication. The required plan depends on the specific opioid, duration of use, dependence risk, procedure, and clinical circumstances.

LDN also matters when surgery or dental work is planned. A surgeon, dentist, anesthesiology team, emergency clinician, prescriber, and pharmacist may need to coordinate pain-management options. Anyone taking LDN should disclose it before a procedure and during emergency care.

Can You Take LDN With a GLP-1 Medication?

This is an increasingly relevant question as medications such as semaglutide and tirzepatide become part of diabetes and weight-management care.

There is no broadly established contraindication that automatically prohibits every patient from using oral LDN with a GLP-1 receptor agonist or a dual GIP and GLP-1 receptor agonist. However, direct clinical evidence evaluating compounded LDN together with semaglutide, tirzepatide, or similar medicines is limited. The combination should therefore be treated as an individualized medication decision, not a proven protocol.

The main crossover involves four practical issues.

1. GLP-1 Therapies Can Affect Gastric Emptying

The current FDA prescribing information for Wegovy, semaglutide and Zepbound, tirzepatide explains that these medicines delay gastric emptying and may affect the absorption of oral medications. The labels do not identify LDN as a specifically proven interaction. They do support reviewing and monitoring oral medicines rather than assuming that timing or absorption can never matter.

Patients should not independently separate, skip, or change the timing of LDN and a GLP-1 based on a social media schedule. The prescribing team should decide whether symptom monitoring or another adjustment is appropriate.

2. Gastrointestinal Symptoms Can Overlap

Nausea, vomiting, abdominal discomfort, diarrhea, constipation, or appetite changes may occur with GLP-1 therapy. Nausea and other gastrointestinal symptoms have also been reported with naltrexone and in LDN research.

If symptoms begin after two therapies are started or changed close together, it may be difficult to determine which medicine, dose change, illness, meal pattern, or other factor contributed. A staggered, clinician-directed plan and a simple symptom timeline may make the evaluation clearer.

3. LDN Is Not the Same as Contrave

Naltrexone is one component of Contrave, an FDA-approved extended-release combination of naltrexone and bupropion used for chronic weight management in defined patients. Contrave is a specific product with a specific formulation, dose, labeling, contraindications, and evidence base.

Compounded LDN is not Contrave. LDN alone is not FDA approved for weight loss, and the existence of Contrave does not establish that adding LDN to semaglutide or tirzepatide improves weight loss. The Contrave prescribing informationalso states that coadministration with other naltrexone-containing products is not recommended.

4. The Treatment Goals Must Stay Separate

A GLP-1 medication may be prescribed for diabetes, obesity, cardiovascular risk reduction in an eligible population, or another approved or clinician-determined purpose. LDN may be considered off label for a different symptom or condition.

Each medication needs its own goal, evidence discussion, safety review, and follow-up plan. Improvement in appetite, weight, pain, fatigue, or another symptom should not automatically be attributed to the combination.

Learn more about Scripx Pharmacy’s medically supervised weight-management and GLP-1 services. The page is educational and does not establish that LDN and a GLP-1 should be used together.

Can LDN Be Taken With Antidepressants?

There is no single answer covering every antidepressant.

The exact medication matters, as do the diagnosis, mood history, seizure risk, liver history, other prescriptions, and reason LDN is being considered. Standard naltrexone labeling includes postmarketing reports involving depression and suicidal thinking, although a causal relationship has not been established. New or worsening depression, agitation, unusual behavior, or suicidal thoughts require prompt clinical attention.

The Contrave distinction is also important here. Contrave contains both naltrexone and the antidepressant bupropion. That does not mean any antidepressant can be casually combined with LDN, and it does not make compounded LDN equivalent to Contrave. Patients already taking bupropion should make sure the prescriber and pharmacist can see all bupropion-containing and naltrexone-containing products to prevent unintentional duplication.

Do not stop an antidepressant abruptly to start LDN. Medication changes should be directed by the clinician managing the mental health condition.

Can LDN Be Taken With Thyroid Medication?

LDN is frequently discussed online in connection with Hashimoto’s disease and hypothyroidism. The published evidence does not establish LDN as a replacement for thyroid hormone or as a proven treatment that restores thyroid function.

No universal direct interaction with thyroid replacement has been established, but that is not the same as proof that every combination is appropriate. Thyroid medication effectiveness is influenced by consistent administration, absorption, food, supplements, and certain other medicines. Symptoms such as fatigue, sleep changes, anxiety, palpitations, weight change, or gastrointestinal discomfort can also have several possible causes.

Patients should keep thyroid medication stable unless the treating clinician changes it and should continue appropriate laboratory and symptom monitoring. LDN should not be used as a reason to reduce or discontinue thyroid replacement without thyroid-specific clinical evidence.

For a broader evidence review, see LDN for autoimmune conditions, including what has actually been studied.

Can LDN Be Taken With a Biologic, DMARD, or Immunosuppressant?

Possibly in selected patients, but there is no general rule that covers every diagnosis and combination.

The prescriber needs to consider the specific biologic or immunosuppressant, disease activity, infection risk, liver and kidney history, planned procedures, other medications, and the exact purpose of adding LDN. A lack of a documented direct interaction does not establish added benefit or show that monitoring can be reduced.

Most importantly, LDN has not been shown to provide the same disease-modifying protection as an established therapy for autoimmune disease. Feeling better does not necessarily prove that joint, intestinal, neurologic, skin, or organ inflammation is controlled.

Read the Scripx decision guide, Can LDN replace a biologic or immunosuppressant?, before considering any treatment change.

What About Vitamins, Herbs, and Supplements?

“Natural” does not mean interaction free.

Dietary supplements may contain multiple active ingredients, vary by formulation, affect the liver or gastrointestinal tract, contribute to sedation or stimulation, and interact with other prescriptions. Product names alone may not reveal every ingredient.

Patients should provide the prescriber and pharmacist with:

1. A photo or exact label for every supplement

2. The amount and frequency used

3. The reason for taking it

4. When it was started

5. Any symptoms that followed

6. Whether the product contains a blend with undisclosed amounts

There is no reliable universal list of supplements that are automatically safe with LDN. A complete review is especially important when supplements and other medicines may affect the liver, mood, sleep, blood pressure, blood sugar, or gastrointestinal function.

LDN Medication Compatibility at a Glance

Medication category	Main question	Current practical takeaway
Opioids	Could naltrexone block analgesia or precipitate withdrawal?	Major safety conflict. Requires direct clinical management and procedure planning.
GLP-1 medicines	Could delayed gastric emptying or overlapping gastrointestinal symptoms complicate oral therapy?	No universal prohibition, but direct LDN combination evidence is limited. Review and monitor the full regimen.
Antidepressants	Are there mood, seizure, liver, duplication, or product-specific concerns?	Do not generalize across the class. Confirm all bupropion-containing and naltrexone-containing products.
Thyroid medication	Is thyroid treatment stable, consistently absorbed, and objectively monitored?	LDN is not a proven replacement for thyroid hormone. Continue thyroid-specific monitoring.
Biologics, DMARDs, and immunosuppressants	Is LDN being added for a symptom or confused with disease modification?	Combination decisions are diagnosis specific. Do not reduce established therapy without specialist direction.
Supplements	What are the exact ingredients, amounts, and overlapping effects?	“Natural” does not guarantee compatibility. Review the actual labels.

A Seven Question Medication Review Before Starting LDN

Bring these questions to the prescriber and pharmacist:

1. Do any current or recent medicines contain an opioid?

2. Is surgery, dental work, or another procedure expected?

3. What is the specific goal of adding LDN?

4. Have all prescriptions, over-the-counter products, and supplements been reviewed?

5. Could another medicine affect absorption, liver function, mood, sleep, or gastrointestinal symptoms?

6. How will we tell which medication caused a benefit or side effect?

7. Who should be contacted before any medicine is started, stopped, or changed?

The Bottom Line

The most important LDN interaction is with opioids. That conflict can affect withdrawal risk, routine pain treatment, emergency care, surgery, and dental procedures.

Other combinations require more nuance. Some patients may be prescribed LDN while taking a GLP-1, antidepressant, thyroid medicine, biologic, immunosuppressant, or supplement. But “no known interaction” is not the same as “proven safe,” and it does not establish that the combination works better.

The GLP-1 crossover is a good example. There is no universal rule prohibiting LDN with semaglutide or tirzepatide, but direct combination evidence is limited. GLP-1 therapies can delay gastric emptying, gastrointestinal symptoms can overlap, and LDN should not be confused with Contrave or promoted as an approved weight-loss treatment.

The safest process is coordinated care. The prescriber defines why each medication is being used. The pharmacist reviews the complete regimen and formulation. The patient tracks meaningful changes without independently adjusting treatment.

Talk With Scripx Pharmacy

If you have an LDN prescription or want to understand how a prescribed compounded preparation fits with your medication list, contact a Scripx compounding pharmacist. You can also review the Scripx Low Dose Naltrexone prescription page for prescription requirements, formulation information, and service availability.

All prescription medications require a valid prescription from a licensed healthcare provider. LDN uses discussed in this article are off label. Compounded medications are not FDA approved.

Frequently Asked Questions

What medications should not be taken with LDN?

Opioid medications are the clearest concern because naltrexone can block opioid effects and may precipitate withdrawal in an opioid-dependent person. Other medications require an individualized review because formal nonopioid interaction studies are limited.

Can I take LDN with semaglutide or Ozempic?

There is no universal contraindication that automatically prohibits every combination, but direct evidence studying compounded LDN with semaglutide is limited. Semaglutide delays gastric emptying and may affect oral medication absorption. The prescriber and pharmacist should review the regimen and overlapping gastrointestinal symptoms.

Can I take LDN with tirzepatide, Mounjaro, or Zepbound?

This requires patient-specific review. Tirzepatide delays gastric emptying and may affect oral medications. Direct clinical evidence evaluating tirzepatide with compounded LDN is limited, so the combination should not be promoted as a proven weight-management protocol.

Does LDN help with weight loss?

LDN alone is not FDA approved for weight loss. Contrave is an FDA-approved extended-release product containing naltrexone and bupropion, but it is not the same as compounded LDN. Evidence for Contrave cannot be transferred to LDN alone or to an LDN and GLP-1 combination.

Can I take LDN with an antidepressant?

Possibly, depending on the exact antidepressant and the patient’s history. The prescriber should review mood symptoms, seizure risk, liver history, and all bupropion-containing or naltrexone-containing products. Do not stop an antidepressant abruptly to start LDN.

Can I take LDN with levothyroxine or another thyroid medicine?

No universal direct interaction has been established, but thyroid treatment depends on consistent absorption and objective monitoring. LDN is not a proven replacement for thyroid hormone. Any change to thyroid medication should come from the treating clinician.

Can LDN be taken with a biologic?

Possibly in selected patients, but the decision is diagnosis and medication specific. LDN has not been proven to replace the disease-modifying effects of a biologic, DMARD, or immunosuppressant.

Can I take supplements with LDN?

That depends on the exact ingredients and the rest of the medication regimen. Supplements can affect the liver, gastrointestinal tract, mood, sleep, blood pressure, or blood sugar. Provide actual labels to the pharmacist rather than relying on a product category or brand name.

What happens if I need opioid pain medicine while taking LDN?

Tell the treating clinician, surgeon, dentist, or emergency team that you take naltrexone. Do not try to overcome the blockade or create your own stopping schedule. Pain management may require a coordinated plan and appropriately monitored alternatives.

Should I stop LDN before surgery?

The plan depends on the procedure, expected pain treatment, formulation, dose, and patient-specific factors. The surgical, anesthesia, prescribing, and pharmacy teams should coordinate the plan. Do not stop or restart LDN without clinical direction.